Buckingham Maintains Buy on RenaissanceRe Holdings, Raises Price Target to $200
Buckingham maintains RenaissanceRe Holdings (NYSE:RNR) with a Buy and raises the price target from $192 to $200.
Buckingham Downgrades Hartford Financial Servs to Neutral, Announces $63 Price Target
Buckingham downgrades Hartford Financial Servs (NYSE:HIG) from Buy to Neutral and announces $63 price target.
UBS Maintains Buy on Bombardier, Lowers Price Target to $2.4
UBS maintains Bombardier (TSX:BBD) with a Buy and lowers the price target from $3.2 to $2.4.
UBS Maintains Buy on Netflix, Lowers Price Target to $400
UBS maintains Netflix (NASDAQ:NFLX) with a Buy and lowers the price target from $405 to $400.
UBS Maintains Neutral on Amgen, Raises Price Target to $238
UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.
Morgan Stanley Maintains Equal-Weight on CMS Energy, Raises Price Target to $67
Morgan Stanley maintains CMS Energy (NYSE:CMS) with a Equal-Weight and raises the price target from $64 to $67.
JP Morgan Initiates Coverage On CubeSmart with Neutral Rating, Announces $32 Price Target
JP Morgan analyst Michael Mueller initiates coverage on CubeSmart (NYSE:CUBE) with a Neutral rating and a $32 price…
Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.
Citigroup Downgrades Estee Lauder Cos to Neutral, Raises Price Target to $230
Citigroup analyst Wendy Nicholson downgrades Estee Lauder Cos (NYSE:EL) from Buy to Neutral and raises the price target…
JMP Securities Initiates Coverage On Cue Biopharma with Market Outperform Rating, Announces $22 Price Target
JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a…